Gene Doping: Human Genetic Technologies and the Future of Sports
Please join us Oct. 11 for the inaugural talk in our new Genetics Perspectives on Policy Seminars (GenePOPS) series, designed to explore and illuminate some of the critical issues at the intersection of human genetics and public policy. Hosted by the Genetics and Public Policy Center, a partnership between Johns Hopkins University and The Pew Charitable Trusts, GenePOPS will feature some of the nations leading scientists, medical practitioners, policymakers, patient advocates, and ethicists as they discuss issues as wide ranging as genetic privacy, reproductive genetics, gene doping in sports, and safety and efficacy of commercial genetic tests.
Our first program features a panel discussion of the science, ethics, and regulation of genetically enhanced athletic prowess. Are the scientific tools available today to use gene therapy or germline modification to boost athletic performance, and if so, should they be used? Would the procedure be detectable through existing tests?
What kinds of pressures would athletes feel to use gene doping if it were available? Would parents be likely to choose genetic athletic enhancement for their children?
Tuesday, Oct. 11, 2005
Kenney Auditorium, Johns Hopkins University
1740 Massachusetts Ave., N.W.
4:00 p.m., reception to follow
Dr. Kathy Hudson, Director, Genetics & Public Policy Center (moderator)
Ms. Melissa Dalio Mierke, Exercise Physiologist and USA Triathlon National Champion
Dr. Tom Murray, Director, The Hastings Center (Chair, Ethical Issues Review Panel, World Anti-Doping Agency)
Dr. Bengt Saltin, Director, Center for Muscle Research, Copenhagen University (Member, Scientific Board, World Anti-Doping Agency)
Dr. H. Lee Sweeney, Chair and Professor of Physiology, Department of Physiology, University of Pennsylvania
Rick Borchelt (202.663.5978); firstname.lastname@example.org )
Audrey Huang (202.663.5979); email@example.com
Please RSVP to Rick or Audrey at the contact information above.